S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12

Laboratory Co. of America Stock Forecast, Price & News

$285.45
+0.12 (+0.04%)
(As of 12/1/2021 12:00 AM ET)
Add
Compare
Today's Range
$284.18
$291.60
50-Day Range
$271.60
$297.23
52-Week Range
$195.88
$309.60
Volume
438,257 shs
Average Volume
655,467 shs
Market Capitalization
$27.32 billion
P/E Ratio
10.13
Dividend Yield
N/A
Beta
1.01
30 days | 90 days | 365 days | Advanced Chart
Receive LH News and Ratings via Email

Sign-up to receive the latest news and ratings for Laboratory Co. of America and its competitors with MarketBeat's FREE daily newsletter.


Laboratory Co. of America logo

About Laboratory Co. of America

Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. It operates through the Drug Development and Diagnostics segments. The Drug Development segment consists of lead optimization, preclinical safety assessment, analytical services, clinical trials, central laboratories, biomarkers, and companion diagnostics, market access, and technology solutions. The Diagnostics segment includes primary care, women's health, specialty medicine, oncology, ACOs, and hospitals and health systems. The company was founded in 1971 and is headquartered in Burlington, NC.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Medical laboratories
Sub-Industry
Health Care Services
Sector
Medical
CUSIP
50540R40
Employees
72,400
Year Founded
1995

Sales & Book Value

Annual Sales
$13.98 billion
Cash Flow
$34.77 per share
Book Value
$96.10 per share

Profitability

Net Income
$1.56 billion
Pretax Margin
22.25%

Debt

Price-To-Earnings

Miscellaneous

Free Float
95,403,000
Market Cap
$27.32 billion
Optionable
Optionable

Company Calendar

Last Earnings
10/27/2021
Today
12/02/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/10/2022

Social Links


MarketRank

Overall MarketRank

2.25 out of 5 stars

Medical Sector

323rd out of 1,392 stocks

Medical Laboratories Industry

8th out of 30 stocks

Analyst Opinion: 2.5Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.9 5 -4 -3 -2 -1 -












Laboratory Co. of America (NYSE:LH) Frequently Asked Questions

Is Laboratory Co. of America a buy right now?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Laboratory Co. of America in the last twelve months. There are currently 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Laboratory Co. of America stock.
View analyst ratings for Laboratory Co. of America
or view top-rated stocks.

How has Laboratory Co. of America's stock been impacted by COVID-19?

Laboratory Co. of America's stock was trading at $158.99 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, LH shares have increased by 79.5% and is now trading at $285.45.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Laboratory Co. of America?

Laboratory Co. of America saw a drop in short interest in November. As of November 15th, there was short interest totaling 1,140,000 shares, a drop of 32.1% from the October 31st total of 1,680,000 shares. Based on an average daily volume of 567,500 shares, the short-interest ratio is currently 2.0 days. Approximately 1.2% of the company's shares are sold short.
View Laboratory Co. of America's Short Interest
.

When is Laboratory Co. of America's next earnings date?

Laboratory Co. of America is scheduled to release its next quarterly earnings announcement on Thursday, February 10th 2022.
View our earnings forecast for Laboratory Co. of America
.

How were Laboratory Co. of America's earnings last quarter?

Laboratory Co. of America Holdings (NYSE:LH) issued its quarterly earnings results on Wednesday, October, 27th. The medical research company reported $6.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.92 by $1.90. The medical research company had revenue of $4.06 billion for the quarter, compared to the consensus estimate of $3.63 billion. Laboratory Co. of America had a net margin of 16.69% and a trailing twelve-month return on equity of 31.56%. The business's quarterly revenue was up 4.3% compared to the same quarter last year. During the same quarter last year, the business posted $8.41 earnings per share.
View Laboratory Co. of America's earnings history
.

What guidance has Laboratory Co. of America issued on next quarter's earnings?

Laboratory Co. of America issued an update on its FY 2021 earnings guidance on Thursday, November, 4th. The company provided EPS guidance of $26.000-$28.000 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $24.160. The company issued revenue guidance of $15.80 billion-$15.94 billion, compared to the consensus revenue estimate of $15.22 billion.

What price target have analysts set for LH?

11 Wall Street analysts have issued 12-month price targets for Laboratory Co. of America's stock. Their forecasts range from $276.78 to $377.00. On average, they expect Laboratory Co. of America's stock price to reach $322.71 in the next twelve months. This suggests a possible upside of 13.1% from the stock's current price.
View analysts' price targets for Laboratory Co. of America
or view top-rated stocks among Wall Street analysts.

Who are Laboratory Co. of America's key executives?

Laboratory Co. of America's management team includes the following people:
  • Adam H. Schechter, Chairman, President & Chief Executive Officer
  • Glenn Andrew Eisenberg, Chief Financial Officer & Executive Vice President
  • Lance V. Berberian, Chief Information & Technology Officer & EVP
  • Brian J. Caveney, Chief Medical Officer, EVP & President-Diagnostics
  • Stephen M. Anderson, Chief Scientific Officer-Covance & Senior VP

What is Adam Schechter's approval rating as Laboratory Co. of America's CEO?

143 employees have rated Laboratory Co. of America CEO Adam Schechter on Glassdoor.com. Adam Schechter has an approval rating of 73% among Laboratory Co. of America's employees.

Who are some of Laboratory Co. of America's key competitors?

What other stocks do shareholders of Laboratory Co. of America own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Laboratory Co. of America investors own include Gilead Sciences (GILD), Micron Technology (MU), Intel (INTC), Pfizer (PFE), Johnson & Johnson (JNJ), NVIDIA (NVDA), Abbott Laboratories (abt), AbbVie (ABBV), Alibaba Group (BABA) and Amgen (AMGN).

What is Laboratory Co. of America's stock symbol?

Laboratory Co. of America trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH."

Who are Laboratory Co. of America's major shareholders?

Laboratory Co. of America's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (8.10%), Wellington Management Group LLP (3.26%), Geode Capital Management LLC (1.92%), Dimensional Fund Advisors LP (1.66%), Alliancebernstein L.P. (1.40%) and Franklin Resources Inc. (1.37%). Company insiders that own Laboratory Co. of America stock include Der Vaart Sandra D Van, Jean-Luc Belingard, Judith C Seltz, Mark S Schroeder, Paul R Kirchgraber, Peter J Wilkinson and R Sanders Williams.
View institutional ownership trends for Laboratory Co. of America
.

Which major investors are selling Laboratory Co. of America stock?

LH stock was sold by a variety of institutional investors in the last quarter, including Nordea Investment Management AB, Viking Global Investors LP, California Public Employees Retirement System, LSV Asset Management, Sumitomo Mitsui Trust Holdings Inc., Balyasny Asset Management LLC, Balyasny Asset Management LLC, and Franklin Resources Inc.. Company insiders that have sold Laboratory Co. of America company stock in the last year include Der Vaart Sandra D Van, Jean-Luc Belingard, Mark S Schroeder, Paul R Kirchgraber, and Peter J Wilkinson.
View insider buying and selling activity for Laboratory Co. of America
or view top insider-selling stocks.

Which major investors are buying Laboratory Co. of America stock?

LH stock was bought by a variety of institutional investors in the last quarter, including Assetmark Inc., Farallon Capital Management LLC, Renaissance Technologies LLC, Skandinaviska Enskilda Banken AB publ , Goldman Sachs Group Inc., Eversept Partners LP, Bank of New York Mellon Corp, and Squarepoint Ops LLC.
View insider buying and selling activity for Laboratory Co. of America
or or view top insider-buying stocks.

How do I buy shares of Laboratory Co. of America?

Shares of LH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Laboratory Co. of America's stock price today?

One share of LH stock can currently be purchased for approximately $285.45.

How much money does Laboratory Co. of America make?

Laboratory Co. of America has a market capitalization of $27.32 billion and generates $13.98 billion in revenue each year. The medical research company earns $1.56 billion in net income (profit) each year or $28.17 on an earnings per share basis.

How many employees does Laboratory Co. of America have?

Laboratory Co. of America employs 72,400 workers across the globe.

Does Laboratory Co. of America have any subsidiaries?

The following companies are subsidiares of Laboratory Co. of America: 1957285 Ontario Inc. dba Quality Underwriting Services, 2089729 Ontario Inc., 2248848 Ontario Inc., 3065619 Nova Scotia Company, 3257959 Nova Scotia Company, 896988 Ontario Limited, 9279-3280 Quebec Inc., Accupath Diagnostic Laboratories Inc., Alpha Medical Laboratory LLC, Assets of Pathology Inc, Beacon LBS IPA Inc., Beacon Laboratory Benefit Solutions Inc., CannAmm GP Inc., CannAmm Limited Partnership, Center for Disease Detection International, Center for Disease Detection LLC, Centrex Clinical Laboratories Inc., Chiltern, Clearstone Central Laboratories (U.S.) Inc., Clearstone Holdings (International) Ltd., Clipper Holdings Inc., Colorado Coagulation Consultants Inc., Colorado Laboratory Services LLC, Correlagen Diagnostics Inc., Covance Inc., Curalab Inc., Cytometry Associates Inc., Czura Thornton (Hong Kong) Limited, DCL Acquisition Inc., DCL Medical Laboratories LLC (DE), DCL Medical Laboratories LLC (FL), DCL Sub LLC, DIANON Systems Inc., DL Holdings Limited Partnership, Decision Diagnostics L.L.C. (aka DaVinici/Medicorp LLC), Diagnostic Services Inc., DynaLifeDX, Dynacare - Gamma Laboratory Partnership, Dynacare Company, Dynacare G.P. Inc., Dynacare Holdco LLC, Dynacare Laboratories Inc., Dynacare Laboratories Limited Partnership, Dynacare Northwest Inc., Dynacare Realty Inc., DynalifeDX Infrastructure Inc., Endocrine Sciences Inc., Esoterix Genetic Counseling LLC, Esoterix Genetic Laboratories LLC, Esoterix Inc., Execmed Health Services Inc., FirstSource Laboratory Solutions Inc., GDML Medical Laboratories Inc, Gamma Dynacare Central Medical Laboratories GP Inc., Gamma Dynacare Central Medical Laboratory Limited Partnership, HHLA Lab-In-An-Envelope LLC, Health Trans Services Inc., Home Healthcare Laboratory of America LLC, IDX Pathology Inc., Impact Genetics Corp, Impact Genetics Inc., Kaleida LabCorp LLC, Lab Delivery Service of New York City Inc., LabCorp BVBA, LabCorp Belgium Holdings Inc., LabCorp Central Laboratories (Canada) Inc., LabCorp Central Laboratories (China) Inc., LabCorp Central Laboratories (Singapore) Pte., LabCorp Development Company, LabCorp Employer Services Inc., LabCorp Health System Diagnostics LLC, LabCorp Indiana Inc., LabCorp Japan G.K., LabCorp Limited, LabCorp Michigan Inc., LabCorp Nebraska Inc., LabCorp Neon Ltd., LabCorp Neon Switzerland S.à.r.l., LabCorp Specialty Testing Billing Service Inc., LabCorp Specialty Testing Group Inc., LabCorp Staffing Solutions Inc., LabCorp Tennessee LLC, LabCorp UK Holdings Ltd., LabWest Inc., Laboratoire Bio-Medic Inc., Laboratory Corporation of America, Lifecodes Corporation, LipoScience Inc., Litholink Corporation, MEDTOX Scientific Inc., MNG Laboratories, Medical Neurogenitics LLC, Medtox Diagnostics Inc., Medtox Laboratories Inc., Monogram Biosciences Inc., Monogram Biosciences UK Limited, Myriad Autoimmune’s Vectra Testing Business, NWT Inc., National Genetics Institute, New Brighton Business Center LLC, New Imaging Diagnostics LLC, New Molecular Diagnostics Ventures LLC, Orchid Cellmark Ltd., Orchid Cellmark ULC, PA Labs Inc., Path Lab Incorporated, Pathology Associates Medical Lab LLC, Pee Dee Pathology Associates Inc., Persys Technology Inc., Pixel by LabCorp, Princeton Diagnostic Laboratories of America Inc., Protedyne Corporation, ReliaGene Technologies Inc., SW/DL LLC, Saint Josephs-PAML LLC, Sequenom Biosciences (India) Pvt. Ltd., Sequenom Center for Molecular Medicine LLC, Sequenom Inc, Sequenom Inc., Southern Idaho Regional Laboratory, Tandem Labs Inc., The LabCorp Charitable Foundation, Tri-Cities Laboratory LLC, Viro-Med Laboratories Inc., Visiun, and Yakima Medical Arts Inc..

When was Laboratory Co. of America founded?

Laboratory Co. of America was founded in 1995.

What is Laboratory Co. of America's official website?

The official website for Laboratory Co. of America is www.labcorp.com.

Where are Laboratory Co. of America's headquarters?

Laboratory Co. of America is headquartered at 358 South Main Street, BURLINGTON NC, 27215.

How can I contact Laboratory Co. of America?

Laboratory Co. of America's mailing address is 358 South Main Street, BURLINGTON NC, 27215. The medical research company can be reached via phone at (336) 229-1127, via email at [email protected], or via fax at 336-513-4510.


This page was last updated on 12/2/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.